TriangleNCT04579679 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- Based upon the strategic reevaluation of the clinical development program for surufatinib in Europe and the United States (US), the study was terminated. The termination was not based on any concern for patient safety or efficacy relative to surufatinib treatment.
- point Of Contact
- nickl@hutch-med.com
- organization
- HUTCHMED International Corporation
- phone
- +44 7826 422448
- title
- Nick Lawn
Complete source fields
- certain Agreement
- pi Sponsor Employee
- false
- restrictive Agreement
- true
- limitations And Caveats
- description
- Based upon the strategic reevaluation of the clinical development program for surufatinib in Europe and the United States (US), the study was terminated. The termination was not based on any concern for patient safety or efficacy relative to surufatinib treatment.
- point Of Contact
- nickl@hutch-med.com
- organization
- HUTCHMED International Corporation
- phone
- +44 7826 422448
- title
- Nick Lawn
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice